Provided by Tiger Trade Technology Pte. Ltd.

CINGULATE INC.

6.39
+0.11001.75%
Post-market: 6.21-0.1800-2.82%19:57 EDT
Volume:370.69K
Turnover:2.29M
Market Cap:74.31M
PE:-1.44
High:6.43
Open:6.21
Low:5.99
Close:6.28
52wk High:11.89
52wk Low:3.20
Shares:11.63M
Float Shares:10.72M
Volume Ratio:0.59
T/O Rate:3.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4408
EPS(LYR):-10.1953
ROE:-450.60%
ROA:-83.25%
PB:29.62
PE(LYR):-0.63

Loading ...

Cingulate CEO Shane J. Schaffer Reports Acquisition of Common Shares

Reuters
·
Feb 11

Cingulate Advances Capital Raise with Private Placement Financing

TIPRANKS
·
Feb 07

Cingulate Inc. Raises $6.5 Million in Private Placement of Unregistered Shares

Reuters
·
Feb 07

BRIEF-Cingulate Enters Securities Purchase Agreement For Private Placement Includes 2.14 Million Common Shares And 973 Preferred Shares

Reuters
·
Jan 29

Cingulate Announces Private Placement and New Preferred Stock

TIPRANKS
·
Jan 29

Cingulate Expands At-The-Market Equity Offering Capacity

TIPRANKS
·
Jan 16

BRIEF-Cingulate Inc Files For Mixed Shelf Offering Of Up To $200 Million- SEC Filing

Reuters
·
Jan 13

Cingulate files $200M mixed securities shelf

TIPRANKS
·
Jan 13

Cingulate Inc : Files for Mixed Shelf Offering of up to $200 Mln- SEC Filing

THOMSON REUTERS
·
Jan 13

Cingulate Inc. Issues Unregistered Shares to Lenders in Debt Exchange

Reuters
·
Jan 03

BRIEF- Shane Schaffer Reinstated As CEO Of Cingulate

Reuters
·
Dec 16, 2025

Cingulate Inc - Shane Schaffer Reinstated as CEO of Cingulate - SEC Filing

THOMSON REUTERS
·
Dec 15, 2025

Cingulate Inc: John Roberts Will No Longer Serve as Exec Chairman but Will Continue to Serve as Chairman of Board

THOMSON REUTERS
·
Dec 15, 2025

Cingulate Inc. Revises CEO Compensation Terms Following Administrative Leave

Reuters
·
Dec 15, 2025

Cingulate Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Dec 08, 2025

Cingulate Is Maintained at Buy by Roth Capital

Dow Jones
·
Nov 20, 2025

Cingulate price target lowered to $16 from $17 at Roth Capital

TIPRANKS
·
Nov 19, 2025

Cingulate Inc. Signs Exclusive Commercial Supply Agreement with Bend Bio Sciences

Reuters
·
Nov 19, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 17, 2025

Cingulate Inc.’s Promising Market Position Bolstered by Strategic Partnerships and Innovative ADHD Treatment

TIPRANKS
·
Nov 16, 2025